391 related articles for article (PubMed ID: 30544839)
1. Neurological and Inflammatory Manifestations in Sjögren's Syndrome: The Role of the Kynurenine Metabolic Pathway.
de Oliveira FR; Fantucci MZ; Adriano L; Valim V; Cunha TM; Louzada-Junior P; Rocha EM
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544839
[TBL] [Abstract][Full Text] [Related]
2. Association of Increased Treg Cell Levels With Elevated Indoleamine 2,3-Dioxygenase Activity and an Imbalanced Kynurenine Pathway in Interferon-Positive Primary Sjögren's Syndrome.
Maria NI; van Helden-Meeuwsen CG; Brkic Z; Paulissen SM; Steenwijk EC; Dalm VA; van Daele PL; Martin van Hagen P; Kroese FG; van Roon JA; Harkin A; Dik WA; Drexhage HA; Lubberts E; Versnel MA
Arthritis Rheumatol; 2016 Jul; 68(7):1688-99. PubMed ID: 26866723
[TBL] [Abstract][Full Text] [Related]
3. Increased Indoleamine 2,3-Dioxygenase Levels at the Onset of Sjögren's Syndrome in SATB1-Conditional Knockout Mice.
Tanaka Y; Onozato M; Mikami T; Kohwi-Shigematsu T; Fukushima T; Kondo M
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576286
[TBL] [Abstract][Full Text] [Related]
4. Pathological Analysis of Ocular Lesions in a Murine Model of Sjögren's Syndrome.
Ushio A; Arakaki R; Eguchi H; Hotta F; Yamada A; Kudo Y; Ishimaru N
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587293
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome. Controversies and progress.
Fox RI
Clin Lab Med; 1997 Sep; 17(3):431-44. PubMed ID: 9316767
[TBL] [Abstract][Full Text] [Related]
6. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
Ampélas JF; Wattiaux MJ; Van Amerongen AP
Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
[TBL] [Abstract][Full Text] [Related]
7. Aging and Immunopathology in Primary Sjögren's Syndrome.
Bouma HR; Bootsma H; van Nimwegen JF; Haacke EA; Spijkervet FK; Vissink A; Kroese FG
Curr Aging Sci; 2015; 8(2):202-13. PubMed ID: 26212053
[TBL] [Abstract][Full Text] [Related]
8. The Potential Role for Early Biomarker Testing as Part of a Modern, Multidisciplinary Approach to Sjögren's Syndrome Diagnosis.
Beckman KA; Luchs J; Milner MS; Ambrus JL
Adv Ther; 2017 Apr; 34(4):799-812. PubMed ID: 28283891
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of interleukin-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation.
Bikker A; van Woerkom JM; Kruize AA; Wenting-van Wijk M; de Jager W; Bijlsma JW; Lafeber FP; van Roon JA
Arthritis Rheum; 2010 Apr; 62(4):969-77. PubMed ID: 20131250
[TBL] [Abstract][Full Text] [Related]
10. Investigation of novel autoantibodies in Sjogren's syndrome utilizing Sera from the Sjogren's international collaborative clinical alliance cohort.
Suresh L; Malyavantham K; Shen L; Ambrus JL
BMC Ophthalmol; 2015 Apr; 15():38. PubMed ID: 25881294
[TBL] [Abstract][Full Text] [Related]
11. Adipose tissue is prominent in salivary glands of Sjögren's syndrome patients and appears to influence the microenvironment in these organs.
Skarstein K; Aqrawi LA; Øijordsbakken G; Jonsson R; Jensen JL
Autoimmunity; 2016 Aug; 49(5):338-46. PubMed ID: 27206986
[TBL] [Abstract][Full Text] [Related]
12. Passive transfer of antibodies to the linear epitope 60 kD Ro 273-289 induces features of Sjögren's syndrome in naive mice.
Maier-Moore JS; Kurien BT; D'Souza A; Bockus L; Asfa S; Dorri Y; Hubbell S; Yeliosof O; Obeso D; Schoeb TR; Jonsson R; Scofield RH
Clin Exp Immunol; 2015 Apr; 180(1):19-27. PubMed ID: 25370295
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of Labial Gland Mesenchymal Stem Cells of Healthy Individuals and Patients with Sjögren's Syndrome: A Preliminary Study.
Wang SQ; Wang YX; Hua H
Stem Cells Dev; 2017 Aug; 26(16):1171-1185. PubMed ID: 28537471
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome.
Soyfoo MS; Chivasso C; Perret J; Delporte C
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700
[TBL] [Abstract][Full Text] [Related]
15. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
16. The complexity of Sjögren's syndrome: novel aspects on pathogenesis.
Jonsson R; Vogelsang P; Volchenkov R; Espinosa A; Wahren-Herlenius M; Appel S
Immunol Lett; 2011 Dec; 141(1):1-9. PubMed ID: 21777618
[TBL] [Abstract][Full Text] [Related]
17. Altered balance of interleukin-13/interferon-gamma contributes to lacrimal gland destruction and secretory dysfunction in CD25 knockout model of Sjögren's syndrome.
Bian F; Barbosa FL; Corrales RM; Pelegrino FS; Volpe EA; Pflugfelder SC; de Paiva CS
Arthritis Res Ther; 2015 Mar; 17(1):53. PubMed ID: 25889094
[TBL] [Abstract][Full Text] [Related]
18. Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases.
Filippini P; Del Papa N; Sambataro D; Del Bufalo A; Locatelli F; Rutella S
Curr Med Chem; 2012; 19(31):5381-93. PubMed ID: 22963664
[TBL] [Abstract][Full Text] [Related]
19. [Neuroradiological manifestations of primary Sjögren's syndrome].
Lafitte C
Rev Neurol (Paris); 2002 Oct; 158(10 Pt 1):959-65. PubMed ID: 12407304
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome in dermatology.
Fox RI; Liu AY
Clin Dermatol; 2006; 24(5):393-413. PubMed ID: 16966020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
